Anti-Infectives Drug Development Summit - April 2021 - Digital Event
Evvnt Promotion / evvnt
Archive
20.04.2021 - 22.04.2021 Online
Time: 08:15 - 17:00
Conference themes
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Speakers: Ercem Atillasoy Chief Regulatory and Safety Officer AlloVir, Martin Everett Chief Scientific Officer AntaBio, Glenn Dale Chief Development Officer BioVersys and more.
Speakers: Ercem Atillasoy Chief Regulatory and Safety Officer AlloVir, Martin Everett Chief Scientific Officer AntaBio, Glenn Dale Chief Development Officer BioVersys and more.
Enquiries and Registration:
https://go.evvnt.com/717995-2?pid=4832
Mr. Customer Service
General Medicine
Languages
English
English
Congress fees
Conference Only: USD 1799.0, Conference + 1 Workshop: USD 2098.0, Conference + 2 Workshops: USD 2397.0
Conference Only: USD 1799.0, Conference + 1 Workshop: USD 2098.0, Conference + 2 Workshops: USD 2397.0
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
